It sometimes feels as if no one’s safe from cyberattacks. The Equifax fiasco is just the latest in a string of attacks, each one seemingly broader in scope than the last. Now it appears that the health-care sector has been affected by cyberattacks more than previously known.
Rep. Greg Walden (R-Ore.) recently sent a letter to Nuance, a Burlington, Mass.-based provider of transcription and dictation services, requesting details on how the company weathered June’s NotPetya malware attack. While Nuance was able to prevent any long-lasting damage, the attack prevented customers from using the company’s services for an extended period of time, which “represents a new challenge in that it is one of the first instances in which a malware infection has so severely disrupted the ability of health care professionals to treat patients,” Walden said in the letter.
The NotPetya attack involved a virus that exploited software vulnerabilities at companies across the globe, encrypting data and locking employees out of their own systems.
The letter demonstrates a growing congressional interest in the cybersecurity of the health-care sector, W. Reece Hirsch, a health-care attorney with Morgan, Lewis & Bockius LLP in San Francisco, told me. Walden and other Republican leaders previously sent a letter to Merck, requesting details on how the NotPetya attack affected the company’s manufacturing capabilities.
Congress may end up encouraging the health-care sector to improve the sharing of cyberthreat data, Hirsch said. However, he said new legislation is unlikely, as the Health Insurance Portability and Accountability Act’s Security Rule is fairly robust as is.
Health-care companies need to make sure that cyberattacks are a part of their regular risk analyses, Hirsch said.
Read my full story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)